Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
XLO Xilio Therapeutics
2.649
-0.071-2.61%
Post Mkt Price
2.6490.0000.00%
YOY
Do not show
Hide blank lines
(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31
Investing cash flow
Cash flow from continuing investing activities
-192.11% -333K -76.03% -771K -49.41% -254K 49.73% -1.1M
Net PPE purchase and sale
-192.11% -333K -76.03% -771K -49.41% -254K 49.73% -1.1M
Cash from discontinued investing activities
Investing cash flow
-192.11% -333K -76.03% -771K -49.41% -254K 49.73% -1.1M
Financing cash flow
Cash flow from continuing financing activities
-107.31% -22K 93.98% -21K -100.00% -5K 2,499.14% 260.67M
Net issuance payments of debt
-107.67% -22K 94.07% -21K 0.00% -21K -11.11% -110K
Net common stock issuance
-- -- -- -- -- -- -- 116.36M
Net preferred stock issuance
-- 0 -- 0 -- 0 1,353.37% 144.89M
Proceeds from stock option exercised by employees
-- 0 -- 0 -36.00% 16K 77.99% 283K
Net other financing activities
-- -- -- -- -- -- -- -750K
Cash from discontinued financing activities
Financing cash flow
-107.31% -22K 93.98% -21K -100.00% -5K 2,499.14% 260.67M
Net cash flow
Beginning cash position
32.10% 160.96M 25.03% 178.51M 860.15% 199.61M -57.61% 20.79M
Current changes in cash
1.31% -20.26M 16.13% -17.55M -117.29% -21.09M 732.98% 178.82M
End cash Position
38.87% 140.7M 32.10% 160.96M 25.03% 178.51M 860.15% 199.61M
Free cash flow
2.84% -20.24M 14.81% -17.53M 7.92% -21.09M -113.83% -81.85M
Investing cash flow
Cash flow from continuing investing activities
-192.11% -333K -76.03% -771K -49.41% -254K 49.73% -1.1M
Net PPE purchase and sale
-192.11% -333K -76.03% -771K -49.41% -254K 49.73% -1.1M
Cash from discontinued investing activities
Investing cash flow
-192.11% -333K -76.03% -771K -49.41% -254K 49.73% -1.1M
Financing cash flow
Cash flow from continuing financing activities
-107.31% -22K 93.98% -21K -100.00% -5K 2,499.14% 260.67M
Net issuance payments of debt
-107.67% -22K 94.07% -21K 0.00% -21K -11.11% -110K
Net common stock issuance
-- -- -- -- -- -- -- 116.36M
Net preferred stock issuance
-- 0 -- 0 -- 0 1,353.37% 144.89M
Proceeds from stock option exercised by employees
-- 0 -- 0 -36.00% 16K 77.99% 283K
Net other financing activities
-- -- -- -- -- -- -- -750K
Cash from discontinued financing activities
Financing cash flow
-107.31% -22K 93.98% -21K -100.00% -5K 2,499.14% 260.67M
Net cash flow
Beginning cash position
32.10% 160.96M 25.03% 178.51M 860.15% 199.61M -57.61% 20.79M
Current changes in cash
1.31% -20.26M 16.13% -17.55M -117.29% -21.09M 732.98% 178.82M
End cash Position
38.87% 140.7M 32.10% 160.96M 25.03% 178.51M 860.15% 199.61M
Free cash flow
2.84% -20.24M 14.81% -17.53M 7.92% -21.09M -113.83% -81.85M
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
------Unqualified Opinion

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on harnessing the immune system to achieve deep and durable clinical responses in cancer. The company uses its proprietary geographically precise solutions platform to rapidly engineer novel molecules, including cytokines and other biologics. Xilio Therapeutics was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.
CEO: Dr. Rene Russo, Pharm.D.
Market: NASDAQ
Listing Date: 10/22/2021
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist